approval · primary record
MELOXICAM
4 approval events · latest 2025-06-05
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-06-05 |
| Approval events | 4 |
| Brand | XIFYRM |
| Sponsor | AZURITY |
| Route | INTRAVENOUS |
Approval history
4 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-06-05 | FDA | NDA | XIFYRM | AZURITY | INTRAVENOUS |
| 2025-04-22 | FDA | NDA | QAMZOVA | NANJING DELOVA | INTRAVENOUS |
| 2025-01-30 | FDA | NDA | SYMBRAVO | AXSOME | ORAL |
| 2024-11-21 | FDA | NDA | MOBIC | BOEHRINGER INGELHEIM | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:27:53.365Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:meloxicam
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Meloxicam · compound